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Abstract
We report the case of a 39-year-old woman who presented with cryptogenic stroke. Conventional and contrast
echocardiography modalities noticed a large Eustachian valve (EV) but failed to identify any right-to-left shunt.
Conversely, contrast-transcranial Doppler revealed a grade 3 right-to-left shunt.
Contrast echocardiography was repeated with bubble injections through both an upper extremity and a femoral vein,
10 min apart from each other. While no shunt was observed following upper extremity injection, >20 bubbles crossed
the inter-atrial septum when contrast was injected via femoral vein conﬁrming the diagnosis of patent foramen ovale.
Keywords: PFO, Contrast echocardiography, Eustachian valve

1. Introduction

P

atent foramen ovale (PFO) is observed in
about 27% of normal healthy adults [1]. There
is growing evidence that PFO is associated with
cryptogenic stroke [1]. An Eustachian valve (EV)
is an embryological remnant that directs the
blood from the inferior vena cava to the area of
the fossa ovalis and is present in up to 70% of
patients with PFO [2]. However, the presence of a
large EV could make challenging the identiﬁcation and the quantiﬁcation of right-to-left shunting through PFO.

2. Case report
We report the case of a 39-year-old woman on oral
contraception who presented with sudden aphasia
and loss of muscular control in right upper and
lower extremities. No prior cerebrovascular accidents or cardiac problems were present in the patient's medical or family history.

Cerebral imaging modalities revealed thrombotic
occlusion of the left middle cerebral artery.
Thrombolysis and thrombectomy were performed
with partial improvement of symptoms.
Transthoracic echocardiography (TTE) showed
normal heart structure with preserved left ventricular ejection fraction and no intracardiac thrombus.
Contrast TTE through an upper extremity vein did
not reveal any atrial shunt. No atrial ﬁbrillation was
detected on holter recording nor was deep venous
thrombosis found in lower extremity venous
doppler.
Contrast-transcranial Doppler (c-TCD) revealed a
grade 3 right-to-left shunt (>10 microemboli).
Nonetheless, conventional color Doppler and
contrast transesophageal echocardiography (TEE)
did not show any atrial shunting neither at rest nor
following a Valsalva maneuver (Figs. 1 and 2).
Importantly, a large Eustachian valve (EV) was
noticed (Fig. 3).
We sought to demonstrate that the presence of a
large EV could alter the accuracy of contrast echocardiography, particularly when injection is performed through upper extremity. Therefore,
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following upper extremity injection (Fig. 4), >20
bubbles crossed the inter-atrial septum (IAS) after
injection from the femoral vein (Fig. 5).
Hence, the diagnosis of patent foramen ovale
(PFO) was made. Percutaneous closure was performed one month later with a 25 mm Amplatzer ™
PFO Occluder (Abbott Vascular) under intracardiac
echocardiography guidance (Fig. 6).

Fig. 1. Contrast TEE showing no atrial shunt. The Eustachian valve
(white arrow) keeps the microbubbles away from the septum. TEE ¼
transesophageal echocardiography.

Fig. 2. Color Doppler TEE showing no atrial shunt. TEE ¼ transesophageal echocardiography.

Fig. 4. Contrast TTE with injection through upper extremity vein.
Contrast bubbles arriving from above (the arm) are kept away from the
atrial septum by the Eustachian valve guiding the blood from below
(IVC via femoral vein) directly onto the PFO and thereby monopolizing
that area (black area to the left of the septum). TTE ¼ transthoracic
echocardiography.

contrast TTE was repeated with injections through
both an upper extremity and a femoral, 10 min apart
from each other. While no contrast reached the area
of the fossa ovalis and no shunt was observed

Fig. 3. Large Eustachian valve noticed on TEE (white arrow). TEE ¼
transesophageal echocardiography.

Fig. 5. Contrast TTE with injection through femoral vein: signiﬁcant
right-to-left shunt (>20 microbubbles). TTE ¼ transthoracic
echocardiography.
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echocardiographic modalities, a signiﬁcant portion
(or all) of the shunting may be missed by the limited
imaging plane, which can be even more difﬁcult to
stabilize during Valsalva.

4. Conclusion

Fig. 6. Percutaneous closure of PFO under ICE guidance. ICE ¼ intracardiac echocardiography; PFO ¼ patent foramen ovale.

The patient followed a rehabilitation program.
Dual anti-platelet anti-aggregation (aspirin and
clopidogrel) was prescribed for 3 months and oral
contraception was stopped permanently.

3. Discussion
Our case demonstrates that the presence of a large
EV can compromise the ability of contrast echocardiography to detect or quantify right-to-left shunting when microbubbles are injected through the
arm. Blood reaching the right atrium (RA) via the
superior vena cava (SVC) interacts with the EV to
follow a course that is unfavourable to PFO ﬂap
opening, as opposed to the preferential direction of
blood travelling from the IVC. Indeed, contrast
entering the RA via the SVC may never reach the
PFO area.
Although, Schuchlenz et al. [3] claimed the superiority of color Doppler echocardiography over
bubble injections in presence of large EV, this modality did not allow PFO detection in our case.
On the other hand, TCD during forced expiration
into a manometer was demonstrated to be more
sensitive than echocardiographic imaging for the
detection of right-to-left shunts [4]. One explanation
is the achievement of higher intrathoracic pressures
and more efﬁcient Valsalva maneuvers obtained
when immediate feedback from a manometer
guides the forced expiration during TCD [4].
Furthermore, the timing of the Valsalva maneuver is
crucial. The PFO opens when the wave of lower
body blood reaches the septum at the end of a
sustained Valsalva maneuver. The microbubbles
should arrive simultaneously with that wave to
allow the detection of interatrial shunt. With

In conclusion, when clinical evaluation suggests
paradoxical embolization, visualization of a ﬁlling
defect adjacent to the interatrial septum during TTE
microbubble injections or direct TEE observation of
a large EV should raise the possibility of PFO
underdetection or shunt magnitude underestimation. In this particular scenario, a multi-modality
diagnostic strategy should be considered using
either TCD with manometer-guided forced expiration and/or echocardiography with contrast injection via lower extremity veins to best orient
discussions about secondary prevention therapies.
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